Cited 0 times in
Usefulness of 18F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, SH | - |
dc.contributor.author | Kim, KS | - |
dc.contributor.author | Kang, SY | - |
dc.contributor.author | Song, HS | - |
dc.contributor.author | Jo, KS | - |
dc.contributor.author | Choi, BH | - |
dc.contributor.author | Lee, SJ | - |
dc.contributor.author | Yoon, JK | - |
dc.contributor.author | An, YS | - |
dc.date.accessioned | 2014-07-18T04:30:02Z | - |
dc.date.available | 2014-07-18T04:30:02Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1869-3474 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/10633 | - |
dc.description.abstract | Purpose: Bone metastasis is an important factor for the treatment and prognosis of breast cancer patients. Whole-body bone scintigraphy (WBBS) can evaluate skeletal metastases, and (18)F-FDG PET/CT seems to exhibit high specificity and accuracy in detecting bone metastases. However, there is a limitation of (18)F-FDG PET in assessing sclerotic bone metastases because some lesions may be undetectable. Recent studies showed that (18)F-fluoride PET/CT is more sensitive than WBBS in detecting bone metastases. This study aims to evaluate the usefulness of (18)F-fluoride PET/CT by comparing it with WBBS and (18)F-FDG PET/CT in breast cancer patients with osteosclerotic skeletal metastases.
Materials and methods: Nine breast cancer patients with suspected bone metastases (9 females; mean age ± SD, 55.6 ± 10.0 years) underwent (99m)Tc-MDP WBBS, (18)F-FDG PET/CT and (18)F-fluoride PET/CT. Lesion-based analysis of five regions of the skeletons (skull, vertebral column, thoracic cage, pelvic bones and long bones of extremities) and patient-based analysis were performed. Results: (18)F-fluoride PET/CT, (18)F-FDG PET/CT and WBBS detected 49, 20 and 25 true metastases, respectively. Sensitivity, specificity, positive predictive value and negative predictive value of (18)F-fluoride PET/CT were 94.2 %, 46.3 %, 57.7 % and 91.2 %, respectively. Most true metastatic lesions on (18)F-fluoride PET/CT had osteosclerotic change (45/49, 91.8 %), and only four lesions showed osteolytic change. Most lesions on (18)F-FDG PET/CT also demonstrated osteosclerotic change (17/20, 85.0 %) with three osteolytic lesions. All true metastatic lesions detected on WBBS and (18)F-FDG PET/CT were identified on (18)F-fluoride PET/CT. Conclusion: (18)F-fluoride PET/CT is superior to WBBS or (18)F-FDG PET/CT in detecting osteosclerotic metastatic lesions. (18)F-fluoride PET/CT might be useful in evaluating osteosclerotic metastases in breast cancer patients. | - |
dc.format | text/plain | - |
dc.language.iso | en | - |
dc.title | Usefulness of 18F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases | - |
dc.type | Article | - |
dc.identifier.pmid | 24895505 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035203/ | - |
dc.subject.keyword | 18F-fluoride | - |
dc.subject.keyword | 18F-NaF . PET/CT | - |
dc.subject.keyword | Breast cancer | - |
dc.subject.keyword | Skeletal metastases | - |
dc.contributor.affiliatedAuthor | 김, 구상 | - |
dc.contributor.affiliatedAuthor | 강, 석윤 | - |
dc.contributor.affiliatedAuthor | 이, 수진 | - |
dc.contributor.affiliatedAuthor | 윤, 준기 | - |
dc.contributor.affiliatedAuthor | 안, 영실 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1007/s13139-012-0178-0 | - |
dc.citation.title | Nuclear medicine and molecular imaging | - |
dc.citation.volume | 47 | - |
dc.citation.number | 1 | - |
dc.citation.date | 2013 | - |
dc.citation.startPage | 27 | - |
dc.citation.endPage | 35 | - |
dc.identifier.bibliographicCitation | Nuclear medicine and molecular imaging, 47(1). : 27-35, 2013 | - |
dc.identifier.eissn | 1869-3482 | - |
dc.relation.journalid | J018693474 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.